<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">74114</article-id><article-id pub-id-type="doi">10.7554/eLife.74114</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Ligand binding remodels protein side chain conformational heterogeneity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-254332"><name><surname>Wankowicz</surname><given-names>Stephanie A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254333"><name><surname>de Oliveira</surname><given-names>Saulo H</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-254334"><name><surname>Hogan</surname><given-names>Daniel W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254335"><name><surname>van den Bedem</surname><given-names>Henry</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-239260"><name><surname>Fraser</surname><given-names>James S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5080-2859</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Department of Bioengineering and Therapeutic Sciences</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Atomwise, Inc</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1054"><name><surname>Brunger</surname><given-names>Axel T</given-names></name><role>Reviewing editor</role><aff><institution>Stanford University School of Medicine, Howard Hughes Medical Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jfraser@fraserlab.com</email> (JF);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e74114</elocation-id><history><date date-type="received"><day>22</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Wankowicz et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Wankowicz et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-74114-v1.pdf"/><abstract><p>While protein conformational heterogeneity plays an important role in many aspects of biological function, including ligand binding, its impact has been difficult to quantify. Macromolecular X-ray diffraction is commonly interpreted with a static structure, but it can provide information on both the anharmonic and harmonic contributions to conformational heterogeneity. Here, through multiconformer modeling of time- and space-averaged electron density, we measure conformational heterogeneity of 743 stringently matched pairs of crystallographic datasets that reflect unbound/apo and ligand-bound/holo states. When comparing the conformational heterogeneity of side chains, we observe that when binding site residues become more rigid upon ligand binding, distant residues tend to become more flexible, especially in non-solvent exposed regions. Among ligand properties, we observe increased protein flexibility as the number of hydrogen bonds decrease and relative hydrophobicity increases. Across a series of 13 inhibitor bound structures of CDK2, we find that conformational heterogeneity is correlated with inhibitor features and identify how conformational changes propagate differences in conformational heterogeneity away from the binding site. Collectively, our findings agree with models emerging from NMR studies suggesting that residual side chain entropy can modulate affinity and point to the need to integrate both static conformational changes and conformational heterogeneity in models of ligand binding.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>GRFP 2034836</award-id><principal-award-recipient><name><surname>Wankowicz</surname><given-names>Stephanie A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM123159</award-id><principal-award-recipient><name><surname>Fraser</surname><given-names>James S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM124149</award-id><principal-award-recipient><name><surname>Fraser</surname><given-names>James S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Saulo H de Oliveira, is an employee of Atomwise Inc..</p></fn><fn fn-type="conflict" id="conf3"><p>Henry van den Bedem, is an employee of Atomwise Inc..</p></fn><fn fn-type="conflict" id="conf4"><p>James S Fraser, has equity, has received consulting fees, and has sponsored research agreements with Relay Therapeutics..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Refined models are available here: https://zenodo.org/record/5533006#.YVJr2Z5KgUsCode can be found in the following repositories:-Dataset selection: https://github.com/stephaniewankowicz/PDB_selection_pipeline-Refinement/qFit pipeline: https://github.com/stephaniewankowicz/refinement_qFit-Analysis/Figures: https://github.com/fraser-lab/Apo_Holo_Analysis-qFit: https://github.com/ExcitedStates/qfit-3.0.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Wankowicz SA</collab><collab>de Oliveira SHP</collab><collab>Hogan DW</collab><collab>van den Bebem H</collab><collab>Fraser JS</collab></person-group><year iso-8601-date="2021">2021</year><source>Ligand binding remodels protein side chain conformational heterogeneity</source><ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/5533006#.YVJr2Z5KgUs">https://zenodo.org/record/5533006#.YVJr2Z5KgUs</ext-link><comment>Zenodo,</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-74114-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>